Multiple studies have shown that KDELR2 is highly expressed in GBM tissues and that its expression levels are negatively correlated with glioma patient prognosis (Fig. 2) [52, 59], suggesting its potential as a prognostic marker [42, 43, 59]. Here, KDELR2 is linked to glioma.